United States · FDA National Drug Code directory

M-M-R II

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0006-4681_4304efd3-eca8-4b1a-bc87-3426d9f5bf73
Product NDC: 0006-4681
Form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Composition / generic term: measles, mumps, and rubella virus vaccine live
Labeler: Merck Sharp & Dohme LLC
Marketing category: BLA
Marketing start / end (source format): 19710421
Source listing expiry: 20261231

Source-listed ingredients

MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN — 1000 [TCID_50]/.5mL
MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN — 12500 [TCID_50]/.5mL
RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN — 1000 [TCID_50]/.5mL

These values do not establish equivalence or a dose recommendation.

Packages

10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4681-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4681-01) · 0006-4681-00

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →